315 related articles for article (PubMed ID: 32588209)
1. Gadoxetate-enhanced abbreviated MRI is highly accurate for hepatocellular carcinoma screening.
Vietti Violi N; Lewis S; Liao J; Hulkower M; Hernandez-Meza G; Smith K; Babb JS; Chin X; Song J; Said D; Kihira S; Sirlin CB; Reeder SB; Bashir MR; Fowler KJ; Ferket BS; Sigel K; Taouli B
Eur Radiol; 2020 Nov; 30(11):6003-6013. PubMed ID: 32588209
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase post gadoxetic acid.
Besa C; Lewis S; Pandharipande PV; Chhatwal J; Kamath A; Cooper N; Knight-Greenfield A; Babb JS; Boffetta P; Padron N; Sirlin CB; Taouli B
Abdom Radiol (NY); 2017 Jan; 42(1):179-190. PubMed ID: 27448609
[TBL] [Abstract][Full Text] [Related]
3. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.
Khatri G; Pedrosa I; Ananthakrishnan L; de Leon AD; Fetzer DT; Leyendecker J; Singal AG; Xi Y; Yopp A; Yokoo T
J Magn Reson Imaging; 2020 Feb; 51(2):415-425. PubMed ID: 31209978
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening.
Tillman BG; Gorman JD; Hru JM; Lee MH; King MC; Sirlin CB; Marks RM
Clin Radiol; 2018 May; 73(5):485-493. PubMed ID: 29246586
[TBL] [Abstract][Full Text] [Related]
5. Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.
Whang S; Choi MH; Choi JI; Youn SY; Kim DH; Rha SE
Eur Radiol; 2020 Aug; 30(8):4150-4163. PubMed ID: 32166493
[TBL] [Abstract][Full Text] [Related]
6. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
[TBL] [Abstract][Full Text] [Related]
7. Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience.
Brunsing RL; Chen DH; Schlein A; Wolfson T; Gamst A; Mamidipalli A; Vietti Violi N; Marks RM; Taouli B; Loomba R; Kono Y; Sirlin CB
Radiol Imaging Cancer; 2019 Nov; 1(2):e190010. PubMed ID: 33778680
[TBL] [Abstract][Full Text] [Related]
8. Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.
Gupta P; Soundararajan R; Patel A; Kumar-M P; Sharma V; Kalra N
J Hepatol; 2021 Jul; 75(1):108-119. PubMed ID: 33548385
[TBL] [Abstract][Full Text] [Related]
9. Abbreviated MRI for HCC surveillance: is it ready for clinical use?
Vietti Violi N; Taouli B
Eur Radiol; 2020 Aug; 30(8):4147-4149. PubMed ID: 32394280
[TBL] [Abstract][Full Text] [Related]
10. Inter-reader agreement of abbreviated magnetic resonance imaging for hepatocellular carcinoma detection: a systematic review and meta-analysis.
Kim DH; Choi SH; Lee JS; Choi JI
Abdom Radiol (NY); 2022 Jan; 47(1):123-132. PubMed ID: 34633497
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
Rong D; He B; Tang W; Xie S; Kuang S; Grazioli L; Hussain SM; Yang Y; Wang J
AJR Am J Roentgenol; 2022 Apr; 218(4):687-698. PubMed ID: 34817191
[No Abstract] [Full Text] [Related]
13. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
14. Lesion detection performance of an abbreviated gadoxetic acid-enhanced MRI protocol for colorectal liver metastasis surveillance.
Canellas R; Patel MJ; Agarwal S; Sahani DV
Eur Radiol; 2019 Nov; 29(11):5852-5860. PubMed ID: 30888485
[TBL] [Abstract][Full Text] [Related]
15. Abbreviated MRI with optional multiphasic CT as an alternative to full-sequence MRI: LI-RADS validation in a HCC-screening cohort.
Park SH; Kim B; Kim SY; Shim YS; Kim JH; Huh J; Kim HJ; Kim KW; Lee SS
Eur Radiol; 2020 Apr; 30(4):2302-2311. PubMed ID: 31858203
[TBL] [Abstract][Full Text] [Related]
16. Characterizing Computed Tomography-Detected Arterial Hyperenhancing-Only Lesions in Patients at Risk of Hepatocellular Carcinoma: Can Non-Contrast Magnetic Resonance Imaging Be Used for Sequential Imaging?
Park SH; Kim B; Kim SY; Choi SJ; Huh J; Kim HJ; Kim KW; Lee SS
Korean J Radiol; 2020 Mar; 21(3):280-289. PubMed ID: 32090520
[TBL] [Abstract][Full Text] [Related]
17. Cost-Utility Analysis of Non-Contrast Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance in Cirrhosis.
Decharatanachart P; Pan-Ngum W; Peeraphatdit T; Tanpowpong N; Tangkijvanich P; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
Gut Liver; 2024 Jan; 18(1):135-146. PubMed ID: 37560799
[TBL] [Abstract][Full Text] [Related]
18. Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging.
Min JH; Kim YK; Choi SY; Kang TW; Jeong WK; Kim K; Won HJ
Br J Radiol; 2018 Oct; 91(1090):20180177. PubMed ID: 29927634
[TBL] [Abstract][Full Text] [Related]
19. Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?
Pahade JK; Juice D; Staib L; Israel G; Cornfeld D; Mitchell K; Weinreb J
Abdom Radiol (NY); 2016 Jul; 41(7):1270-84. PubMed ID: 26800701
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis of the Accuracy of Abbreviated Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Non-Contrast versus Hepatobiliary Phase-Abbreviated Magnetic Resonance Imaging.
Kim DH; Choi SH; Shim JH; Kim SY; Lee SS; Byun JH; Choi JI
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34198589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
